Dr. Davies - The Combination of Velcade, Idarubicin and Melphalan (VIM) Demonstrates Significant Clinical Activity in Relapsed/Refractory Myeloma Patients
Faith E. Davies, MD The Royal Marsden NHS Foundation Trust Sutton, Surrey, UK Member, IMF Board of Scientific Advisors
back
print
related articles
Be the first to comment